{"disease":{"id":"hyperparathyroidism-secondary","name":"hyperparathyroidism secondary"},"drugs":{"marketed":[{"drug_id":"ergocalciferol","indication_name":"Hyperparathyroidism Secondary to Chronic Renal Failure with Dialysis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Drisdol","generic_name":"ERGOCALCIFEROL","company_name":"Esjay Pharma","drug_phase":"marketed","molecular_target":"25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial","drug_class":"Provitamin D2 Compound [EPC]","quality_score":42,"revenue":null,"mechanism":""},{"drug_id":"paricalcitol","indication_name":"Hyperparathyroidism Secondary to Chronic Renal Failure","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zemplar","generic_name":"PARICALCITOL","company_name":"AbbVie","drug_phase":"marketed","molecular_target":"Vitamin D3 receptor","drug_class":"Vitamin D2 Analog [EPC]","quality_score":10,"revenue":null,"mechanism":"Zemplar works by activating the Vitamin D3 receptor, mimicking the natural effects of Vitamin D to regulate calcium levels and bone health."},{"drug_id":"cinacalcet","indication_name":"Hyperparathyroidism Secondary to Chronic Renal Failure with Dialysis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Sensipar","generic_name":"CINACALCET","company_name":"Amgen","drug_phase":"marketed","molecular_target":"Extracellular calcium-sensing receptor","drug_class":"Calcium-sensing Receptor Agonist","quality_score":65,"revenue":null,"mechanism":"Sensipar works by activating the calcium-sensing receptor, which helps regulate calcium levels in the blood."},{"drug_id":"calciferol","indication_name":"Hyperparathyroidism Secondary to Chronic Renal Failure with Dialysis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Calciferol","company_name":"Department of Medical Services Ministry of Public Health of Thailand","drug_phase":"phase_1","molecular_target":"Vitamin D 25-hydroxylase, 25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial, Vitamin D3 receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"doxercalciferol","indication_name":"Hyperparathyroidism Secondary to Chronic Renal Failure with Dialysis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hectorol","generic_name":"DOXERCALCIFEROL","company_name":"Sanofi","drug_phase":"marketed","molecular_target":"Vitamin D3 receptor","drug_class":"Vitamin D2 Analog [EPC]","quality_score":70,"revenue":null,"mechanism":"Hectorol works by activating the Vitamin D receptor, which helps regulate calcium levels in the body."},{"drug_id":"calcitriol","indication_name":"Hyperparathyroidism Secondary to Chronic Renal Failure","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Calcijex","generic_name":"CALCITRIOL","company_name":"Esjay Pharma","drug_phase":"marketed","molecular_target":"Vitamin D3 receptor","drug_class":"Vitamin D3 Analog [EPC]","quality_score":60,"revenue":null,"mechanism":""},{"drug_id":"zemplar","indication_name":"Hyperparathyroidism Secondary to Chronic Renal Failure","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Zemplar","company_name":"Danderyd Hospital","drug_phase":"marketed","molecular_target":"Vitamin D3 receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"rocaltrol","indication_name":"Hyperparathyroidism Secondary to Chronic Renal Failure","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Rocaltrol","company_name":"Shandong University","drug_phase":"marketed","molecular_target":"Vitamin D 25-hydroxylase, 25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial, Vitamin D-binding protein","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":8,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02102204","title":"Extension Study of Etelcalcetide for Treatment of Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease on Hemodialysis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":902,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT01785875","title":"Extension Study of Etelcalcetide in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":891,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT03123406","title":"Efficacy and Safety of Cinacalcet in Ca, P and iPTH Levels in Patients With Mild, Moderate and Severe SHPT","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":750,"lead_sponsor_name":"Kyowa Kirin China Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT01788046","title":"Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":515,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT01785849","title":"Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease on Hemodialysis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":508,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT01181531","title":"Compare the Efficacy of Cinacalcet vs Traditional Vitamin D for Secondary Hyperparathyroidism (SHPT) Among Subjects Undergoing Hemodialysis","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":312,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT01932970","title":"Study to Assess the Impact on Calcium Levels When Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT) Switch From Cinacalcet to Etelcalcetide","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":158,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT03724188","title":"Impact of Parathyroidectomy on Vascular Calcification and Clinical Outcome in Hemodialysis Patients","phase":"","overall_status":"COMPLETED","enrollment_count":55,"lead_sponsor_name":"Mansoura General Hospital","has_results":false},{"nct_id":"NCT04523974","title":"Preemptive and Precise Intervention for CKD-SHPT","phase":"","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Shanghai Zhongshan Hospital","has_results":false},{"nct_id":"NCT05347082","title":"Frequency of Hyperparathyroidism in Postmenopausal Osteoporosis and Its Treatment","phase":"NA","overall_status":"COMPLETED","enrollment_count":47,"lead_sponsor_name":"Hospital Regional 1o de Octubre","has_results":false},{"nct_id":"NCT01277510","title":"Pediatric Chronic Kidney Disease Safety and Efficacy","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":43,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT04637360","title":"Bone Markers and Bone Density Changes in Hyperperparathyroid Dialysis Patients Under Cinacalcet Treatment","phase":"NA","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Min-Sheng General Hospital","has_results":false},{"nct_id":"NCT01134549","title":"Safety, Tolerability and Pharmacokinetics of Etelcalcetide in Healthy Male Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"KAI Pharmaceuticals","has_results":true},{"nct_id":"NCT01134562","title":"Safety, Tolerability and Pharmacokinetics of Etelcalcetide in Hemodialysis Patients With Secondary Hyperparathyroidism","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":28,"lead_sponsor_name":"KAI Pharmaceuticals","has_results":true},{"nct_id":"NCT03960437","title":"The Effect of Etelcalcetide on CKD-MBD","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":22,"lead_sponsor_name":"Thomas Nickolas, MD MS","has_results":true},{"nct_id":"NCT01439867","title":"Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":18,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT01290029","title":"Study to Evaluate Cinacalcet in Children With Chronic Kidney Disease","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":14,"lead_sponsor_name":"Amgen","has_results":true}],"total":17},"guidelines":[],"source":"Drug Landscape verified database"}